SightfileU.S. market data from official filings
Companies › SDGR
SCHRODINGER INC (SDGR)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001490978 · EDGAR filings · Updated 2026-07-17
SCHRODINGER INC (SDGR) has reported institutional ownership of 89.0%, with 227 institutional managers holding positions valued at $748.4M per the latest 13F reporting period.
Institutional ownership
89.0%
Institutional managers
227
Reported 13F value
$748.4M
Insider activity
47 trans.
−$742.2K net selling
Latest updates
- 2026-07-17 — Insider transaction reported (Form 4)
- 2026-07-16 — Notice of proposed sale filed (Form 144)
- 2026-07-01 — Notice of proposed sale filed (Form 144)
- 2026-06-29 — Insider transaction reported (Form 4)
- 2026-06-29 — Current report (8-K) filed
- 2026-06-23 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, SCHRODINGER INC has 227 institutional holders and institutional ownership of 89.0%.
Insider activity
Insiders reported 47 transactions (0 buys, 18 sells) across 19 reporting insiders, with a net reported value of −$742.2K.
Related companies
PHATHOM PHARMACEUTICALS INC (PHAT) · HARROW INC (HROW) · ARS PHARMACEUTICALS INC (SPRY) · GERON CORP (GERN) · IRADIMED CORP (IRMD) · SOLID BIOSCIENCES INC (SLDB)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-17.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-17.